Golden Opportunities Fund Invests $1.5 Million Into Nutraceutical Products Company!

June 28, 2005

Release Date: June 28, 2005

Golden Opportunities Fund is pleased to announce an investment of $1.5 million into Cevena Bioproducts Inc. providing the Fund with approximately 18% ownership in the company. Cevena Bioproducts, headquartered in Edmonton with offices in Saskatoon, is a supplier of proprietary, natural, science-based cholesterol-lowering ingredients to the rapidly growing nutraceutical products market. This investment is part of a $6.0 million syndicated financing with three other senior venture capital firms, making this one of the largest health and nutritional financings in Canada this year.

The financing will ensure Cevena’s successful commercialization of Viscofiber, the highest quality beta-glucan concentrate, derived from oats and barley, available to the food and dietary supplement markets. This novel and clinically proven ingredient offers unsurpassed heart-health and satiety benefits to the supplement and food markets. Viscofiber, Cevena’s lead product, is derived from oats and barley via a patented fractionation process that yields the richest, highest quality beta-glucan ingredient on the market today. Viscofiber was recently launched successfully in the United Sates.

Grant Kook, CEO/Chairman of Golden Opportunities Fund states “a major investment into the health sector with a sophisticated syndication group is a fundamentally sound decision. The decision to invest into a company that has patented technology that has unlimited potential for health, is exciting.”

Kim Lucas, Cevena’s President and CEO commented upon the closing of the investment: “This investment enables us to continue to exceed expectations and to provide consumers with a safe, effective and convenient means of keeping themselves heart-healthy.”

Golden Opportunities Fund Inc. is Saskatchewan’s first and largest Provincial Labour-sponsored Fund, having raised over $62 million in share capital to date from approximately 10,000 shareholders. The company has completed 53 investment transactions in 37 different Saskatchewan growth companies across 9 different industry sectors for diversification, impacting the future of Saskatchewan.

For additional information please contact Mr. Grant Kook, CEO/Chairman of the Fund at (306) 652-5557 or Mr. Kim Lucas, President and CEO of Cevena Bioproducts Inc. at (780) 436-6002.

Saskatchewan Financial Services Commission has neither approved nor disapproved the information contained herein.